Arthur J. Gallagher stock: recent returns put valuation in focus
Arthur J. Gallagher (AJG) has drawn investor attention after a past 3 months total return of about a 17% decline and a 1 year total return near a 35% decline, prompting closer scrutiny of its current valuation.
See our latest analysis for Arthur J. Gallagher.
The recent 7 day share price return of 3.4% sits against a 90 day share price return decline of 17.1% and a 1 year total shareholder return decline of 35.3%. This suggests that momentum has cooled after previously stronger multi year gains.
If this shift in sentiment has you reassessing your options, it could be a good time to widen your search and check out 20 top founder-led companies
With the share price under pressure despite revenue of US$13,009.0m and net income of US$1,494.0m, plus a reported intrinsic discount of about 37%, is this an undervalued insurer or a stock that has already priced in its future growth?
Most Popular Narrative: 55.5% Undervalued
Against the last close at $216.28, the most followed narrative from London_Investment_Analysts points to a fair value of $485.74. This puts a sharp spotlight on the gap between price and perceived potential.
Arthur J. Gallagher & Co. (AJG) has been on an acquisition spree, with significant purchases including AssuredPartners, AnotherDay, Buck, and several others. These strategic moves are set to enhance Gallagher's market position and drive substantial growth in the coming year.
Curious how a traditional insurance broker ends up with a fair value more than double its last close? The narrative leans heavily on acquisition driven revenue expansion, margin assumptions and a premium future earnings multiple that would usually be reserved for faster growing sectors. Want to see how those ingredients combine into that $485.74 figure? The full story sits in the detailed narrative behind this valuation.
Result: Fair Value of $485.74 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that story can crack if acquisition integrations disappoint or if the recent share issuance weighs on per share metrics for a longer period than investors expect.
Find out about the key risks to this Arthur J. Gallagher narrative.
Another view: earnings multiple sends a different signal
That $485.74 fair value hinges on growth, margins and acquisitions all aligning. The current P/E of 37.2x is far higher than the US Insurance industry at 10.8x, the peer average at 19.5x and even the fair ratio estimate of 16.9x. That gap points to meaningful valuation risk if expectations reset.
Before relying on any single number, it helps to see how those comparisons fit together in a simple valuation breakdown, then decide what kind of risk-reward mix suits you, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this mix of caution and optimism has you thinking harder about AJG, it makes sense to move quickly and check the 4 key rewards and 2 important warning signs
Looking for more investment ideas?
If AJG has sharpened your focus, do not stop here. Use the screener to quickly surface fresh ideas that match the kind of opportunities you want to pursue.
- Pinpoint income opportunities by assessing companies that appear to offer resilient payouts with the 13 dividend fortresses.
- Zero in on value by comparing businesses that combine quality fundamentals with appealing pricing using the 58 high quality undervalued stocks.
- Prioritize peace of mind by checking companies that currently screen with lower risk profiles through the 73 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com